ZA955782B - Heterocycle-condensed morphinoid derivatives - Google Patents

Heterocycle-condensed morphinoid derivatives

Info

Publication number
ZA955782B
ZA955782B ZA955782A ZA955782A ZA955782B ZA 955782 B ZA955782 B ZA 955782B ZA 955782 A ZA955782 A ZA 955782A ZA 955782 A ZA955782 A ZA 955782A ZA 955782 B ZA955782 B ZA 955782B
Authority
ZA
South Africa
Prior art keywords
pct
heterocycle
sec
condensed
date
Prior art date
Application number
ZA955782A
Other languages
English (en)
Inventor
Giulio Dondio Silvano Ronzoni
Original Assignee
Smithkline Beecham Farma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Farma filed Critical Smithkline Beecham Farma
Publication of ZA955782B publication Critical patent/ZA955782B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
ZA955782A 1994-07-14 1995-07-22 Heterocycle-condensed morphinoid derivatives ZA955782B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI941463A IT1270612B (it) 1994-07-14 1994-07-14 Derivati eterociclo-condensatori di morfinoidi

Publications (1)

Publication Number Publication Date
ZA955782B true ZA955782B (en) 1996-02-26

Family

ID=11369271

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA955782A ZA955782B (en) 1994-07-14 1995-07-22 Heterocycle-condensed morphinoid derivatives

Country Status (19)

Country Link
US (1) US5981540A (de)
EP (1) EP0770081B1 (de)
JP (1) JP3480936B2 (de)
CN (1) CN1051086C (de)
AT (1) ATE236169T1 (de)
AU (1) AU686413B2 (de)
BR (1) BR9508406A (de)
CA (1) CA2194877A1 (de)
CZ (1) CZ9897A3 (de)
DE (1) DE69530205T2 (de)
ES (1) ES2196069T3 (de)
HU (1) HUT76812A (de)
IT (1) IT1270612B (de)
MX (1) MX9700373A (de)
NO (1) NO315119B1 (de)
NZ (1) NZ289858A (de)
PL (1) PL182747B1 (de)
WO (1) WO1996002545A1 (de)
ZA (1) ZA955782B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985880A (en) * 1996-06-05 1999-11-16 Delta Pharmaceuticals Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
KR19990077125A (ko) * 1996-01-10 1999-10-25 파올로 비지, 엔리꼬 카쭐라니 헤테로고리-축합 모르핀 유도체 (ⅱ)
US6103722A (en) * 1997-07-23 2000-08-15 The Medical College Of Wisconsin Research Foundation Inc. Ischemic preconditioning
IT1312083B1 (it) * 1999-04-20 2002-04-04 Smithkline Beecham Spa Derivati morfinoidi, procedimento per la loro preparazione e loroimpiego terapeutico.
US7015326B1 (en) * 1999-08-13 2006-03-21 Southern Research Institute Pyridomorphinans, thienomorphinans and use thereof
ATE267014T1 (de) 1999-08-13 2004-06-15 Southern Res Inst Pyridomorphinanen und ihre verwendung
WO2001012197A1 (en) * 1999-08-13 2001-02-22 Southern Research Institute Pyridomorphinans, thienomoprhinans and use thereof
GB0025056D0 (en) * 2000-10-12 2000-11-29 Smithkline Beecham Spa Novel compounds
US7541364B2 (en) * 2003-08-27 2009-06-02 Southern Research Institute Pyridomorphinans, pyridazinomorphinans and use thereof
AU2013256203B2 (en) * 2012-05-02 2018-02-01 Southern Research Institute Heterocycle-fused morphinans, use thereof and preparation thereof
JP6173431B2 (ja) * 2013-03-08 2017-08-02 学校法人北里研究所 モルヒナン誘導体
WO2015192039A1 (en) * 2014-06-13 2015-12-17 Purdue Pharma L.P. Heterocyclic morphinan derivatives and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223507A (en) * 1992-01-21 1993-06-29 G. D. Searle & Co. Method of using opioid compounds as delta opioid selective agonist analgesics
US5225417A (en) * 1992-01-21 1993-07-06 G. D. Searle & Co. Opioid agonist compounds

Also Published As

Publication number Publication date
NO315119B1 (no) 2003-07-14
JP3480936B2 (ja) 2003-12-22
ES2196069T3 (es) 2003-12-16
US5981540A (en) 1999-11-09
CZ9897A3 (en) 1997-07-16
AU2982495A (en) 1996-02-16
DE69530205T2 (de) 2004-02-05
NZ289858A (en) 1998-01-26
ITMI941463A0 (it) 1994-07-14
HUT76812A (en) 1997-11-28
AU686413B2 (en) 1998-02-05
IT1270612B (it) 1997-05-07
BR9508406A (pt) 1997-12-23
ATE236169T1 (de) 2003-04-15
DE69530205D1 (de) 2003-05-08
MX9700373A (es) 1998-03-31
NO970142L (no) 1997-03-12
EP0770081A1 (de) 1997-05-02
WO1996002545A1 (en) 1996-02-01
EP0770081B1 (de) 2003-04-02
JPH10502657A (ja) 1998-03-10
CN1161041A (zh) 1997-10-01
PL318148A1 (en) 1997-05-12
ITMI941463A1 (it) 1996-01-14
PL182747B1 (pl) 2002-02-28
CA2194877A1 (en) 1996-02-01
CN1051086C (zh) 2000-04-05
HU9700073D0 (en) 1997-02-28
NO970142D0 (no) 1997-01-13

Similar Documents

Publication Publication Date Title
MY129596A (en) Quinoline derivatives as tachykinin nk3 receptor antagonists
HUT77925A (hu) Dihidrobenzofuránok, azokat tartalmazó gyógyászati készítmények és eljárás előállításukra
SI0882021T1 (en) New phenanthridines
NZ326331A (en) Heterocycle-condensed morphinoid derivatives and medicaments
UA48946C2 (uk) Арилалкілдіазинони, спосіб їх одержання (варіанти), фармацевтичний склад, спосіб його одержання та спосіб лікування
CY2431B1 (en) Novel phenanthridines substituted in the 6 position.
HK1029922A1 (en) Angiostatic agents and compositions for treating glc1a glaucoma
PL333429A1 (en) Benzonaphtyridines useful in particular in treating bronchial diseases
TR200202323T2 (tr) Akut akciğer harabiyeti ve fibrozitinin alfavß6 antagonistleriyle tedavisi
HU9700073D0 (en) Heterocycle-condensed morphinoid derivatives
NZ332585A (en) Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
GR3030626T3 (en) 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
NO982778D0 (no) Morfinderivater med smertestillende virkning
ZA956477B (en) N-substituted 3-azabicyclo[3.2.0] heptane derivatives, the preparation and use thereof.
BG104291A (en) 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use
NZ335052A (en) Piperazino derivatives as neurokinin antagonists
BG104839A (en) Chrystalline form of paroxetine
AP2000001963A0 (en) Paroxetine ascorbate.
ATE294802T1 (de) 3-alkylimidazopyridine
BG105549A (en) Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
ZA962946B (en) Anellated beta-carbolines
MX9701532A (es) Procedimiento para aumentar los niveles de testosterona.